Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis

NCT02808390 is registered in ClinicalTrials.gov with PPM Services S.A. as lead sponsor.

NCT NCT02808390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis
Lead sponsor
PPM Services S.A.
Phase
Phase 2
Overall status
Terminated
Start date
November 28, 2016
Completion date
July 31, 2017
Enrollment
19 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis